NIH-funded research NIH-funded research

How a protein complex regulates gene expression and cellular functions

Official title: Post-transcriptional gene regulation by the exon junction complex

Funded at Ohio State University · NIH-11057508 · Data updated 2026-11-12

This study is looking at how a special protein complex helps control gene activity in our cells, which is important for development and can affect conditions like autism and intellectual disabilities, and it's for anyone interested in understanding how our genes work.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionOhio State University
NIH-funded
Lab location1 site (Columbus, UNITED STATES)
Project startApril 1, 2023
Project endMarch 31, 2028
Funding year2025
Award (this year)$341,175
NIH project number5R35GM149298-03
Project IDNIH-11057508 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals with genetic mutations linked to developmental disorders, particularly those related to autism spectrum disorder.

Less likely to help

Patients without genetic mutations affecting gene regulation or those with unrelated conditions may not benefit from this research.

What this research studies

This research investigates the role of the exon junction complex (EJC) in regulating gene expression through a process called Nonsense-Mediated mRNA Decay (NMD). By studying how EJC interacts with mRNA in human cells and zebrafish embryos, the researchers aim to uncover mechanisms that control cellular functions and responses, particularly in relation to developmental processes and diseases. The study employs a variety of techniques, including genetic and biochemical methods, to explore how disruptions in this regulation can lead to conditions like autism and intellectual disabilities.

Why it matters

Potential benefit: If successful, this research could lead to new insights and therapeutic strategies for conditions associated with gene regulation disorders, such as autism spectrum disorder.

How similar studies have gone: Previous research has shown that understanding mRNA surveillance pathways can lead to significant advancements in treating genetic disorders, indicating a promising avenue for this study.

Where this research is happening

  • Ohio State University
    Columbus, United States
    Active

Researchers

  • Principal investigator: Singh, Guramrit — Ohio State University
  • Study coordinator: Singh, Guramrit

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.